Free Trial

Integrated BioPharma (INBP) Short Interest Ratio & Short Volume

Integrated BioPharma logo
$0.34 0.00 (0.00%)
As of 03/31/2025

Integrated BioPharma Short Interest Data

Integrated BioPharma (INBP) has a short interest of 4,800 shares, representing 0.05% of the float (the number of shares available for trading by the public). This marks a 1,500.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 19,815 shares to cover all short positions.

Current Short Interest
4,800 shares
Previous Short Interest
300 shares
Change Vs. Previous Month
+1,500.00%
Dollar Volume Sold Short
$1,521.12
Short Interest Ratio
0.3 Days to Cover
Last Record Date
March 15, 2025
Outstanding Shares
30,301,000 shares
Short Percent of Float
0.05%
Today's Trading Volume
0 shares
Average Trading Volume
19,815 shares
Today's Volume Vs. Average
0%
Short Selling Integrated BioPharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Integrated BioPharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INBP Short Interest Over Time

INBP Days to Cover Over Time

INBP Percentage of Float Shorted Over Time

Remove Ads

Integrated BioPharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/15/20254,800 shares $1,521.12 +1,500.0%0.0%0.3 $0.32
2/28/2025300 shares $88.50 -25.0%0.0%0 $0.30
2/15/2025400 shares $120.00 -83.3%0.0%0 $0.30
1/31/20252,400 shares $936.00 +60.0%N/A0.5 $0.39
1/15/20251,500 shares $560.70 +7.1%N/A0.1 $0.37
12/31/20241,400 shares $461.58 No ChangeN/A0.1 $0.33
11/15/20246,400 shares $2,176.00 +23.1%N/A0.5 $0.34
10/31/20245,200 shares $1,664.00 +2,500.0%N/A0.1 $0.32
10/15/2024200 shares $50.00 -60.0%N/A0 $0.25
9/30/2024500 shares $117.20 -28.6%N/A0.1 $0.23
9/15/2024700 shares $160.93 +600.0%N/A0 $0.23
8/31/2024100 shares $19.00 No ChangeN/A0 $0.19
8/15/2024100 shares $16.38 No ChangeN/A0 $0.16
7/31/2024100 shares $20.00 No ChangeN/A0.5 $0.20
7/15/2024100 shares $20.00 No ChangeN/A0.1 $0.20
6/30/2024100 shares $21.00 No ChangeN/A0.5 $0.21
6/15/2024100 shares $22.32 No ChangeN/A0.4 $0.22
5/31/2024100 shares $25.00 No ChangeN/A0.1 $0.25
5/15/2024100 shares $22.00 No ChangeN/A0 $0.22
4/30/2024100 shares $21.00 No ChangeN/A0.1 $0.21
4/15/2024100 shares $21.50 No ChangeN/A0 $0.22
11/15/20231,000 shares $270.00 -70.6%N/A0.1 $0.27
10/31/20233,400 shares $822.12 -15.0%N/A0.1 $0.24
10/15/20234,000 shares $1,060.00 +700.0%N/A0.7 $0.27
9/30/2023500 shares $140.00 -70.6%N/A0 $0.28
9/15/20231,700 shares $484.50 No ChangeN/A1.7 $0.29
8/31/20231,700 shares $477.70 No ChangeN/A1.7 $0.28
8/15/20231,700 shares $510.15 +240.0%N/A8.5 $0.30
7/31/2023500 shares $165.20 No ChangeN/A0 $0.33
7/15/2023500 shares $167.40 No ChangeN/A0 $0.33
6/30/2023500 shares $165.61 No ChangeN/A0.3 $0.33
6/15/2023500 shares $165.00 -37.5%N/A0.4 $0.33
5/31/2023800 shares $272.00 +60.0%N/A0.3 $0.34
5/15/2023500 shares $190.00 No ChangeN/A0.1 $0.38
4/30/2023500 shares $190.00 No ChangeN/A0.2 $0.38
4/15/2023500 shares $189.88 -80.8%N/A0.1 $0.38
3/31/20232,600 shares $995.80 -42.2%N/A0.7 $0.38
3/15/20234,500 shares $1,755.00 -25.0%N/A2.5 $0.39
2/28/20236,000 shares $2,640.00 +62.2%N/A1.4 $0.44
2/15/20233,700 shares $1,457.80 +2.8%N/A0.3 $0.39
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.

There's no time to waste. As far as I can tell, the best way to profit from this project is to make
1/31/20233,600 shares $1,260.00 +2.9%N/A1.2 $0.35
1/15/20233,500 shares $1,540.00 No ChangeN/A11.7 $0.44
12/30/20223,500 shares $1,461.25 No ChangeN/A5.8 $0.42
12/15/20223,500 shares $1,348.20 +133.3%N/A0.8 $0.39
11/30/20221,500 shares $574.50 +650.0%N/A0.3 $0.38
11/15/2022200 shares $86.00 No ChangeN/A0.1 $0.43
9/15/20221,300 shares $662.35 No ChangeN/A0.1 $0.51
6/15/20221,800 shares $1,083.60 +125.0%N/A0.2 $0.60
5/31/2022800 shares $647.60 -55.6%N/A0.1 $0.81
5/15/20221,800 shares $1,439.10 -88.5%N/A0.1 $0.80
4/30/202215,600 shares $12,324.00 +766.7%N/A0.7 $0.79
4/15/20221,800 shares $1,440.00 +1,700.0%N/A0.1 $0.80
3/31/2022100 shares $78.95 -97.2%N/A0 $0.79
3/15/20223,600 shares $3,024.00 +28.6%N/A0.3 $0.84
2/28/20222,800 shares $2,658.60 -42.9%N/A0.2 $0.95
2/15/20224,900 shares $4,753.00 No ChangeN/A0.1 $0.97
1/15/20223,300 shares $3,531.00 +22.2%N/A0.2 $1.07
12/31/20212,700 shares $2,808.00 +17.4%N/A0.1 $1.04
12/15/20212,300 shares $2,252.85 -54.0%N/A0.1 $0.98
11/30/20215,000 shares $4,947.50 +4,900.0%N/A0.1 $0.99
11/15/2021100 shares $92.50 -95.2%N/A0 $0.93
10/29/20212,100 shares $2,226.00 +600.0%N/A0.4 $1.06
10/15/2021300 shares $327.00 +50.0%N/A0 $1.09
9/30/2021200 shares $210.00 -50.0%N/A0 $1.05
9/15/2021400 shares $448.00 +33.3%N/A0 $1.12
8/31/2021300 shares $282.00 -90.3%N/A0 $0.94
8/13/20213,100 shares $2,974.45 +3,000.0%N/A0.1 $0.96
7/30/2021100 shares $104.00 -94.4%N/A0 $1.04
7/15/20211,800 shares $1,931.40 +50.0%N/A0.1 $1.07
6/30/20211,200 shares $1,320.00 -67.6%N/A0 $1.10
6/15/20213,700 shares $4,366.00 +516.7%N/A0.1 $1.18
5/28/2021600 shares $732.00 +500.0%N/A0 $1.22
5/14/2021100 shares $118.00 -75.0%N/A0 $1.18
4/30/2021400 shares $420.00 +100.0%N/A0 $1.05
4/15/2021200 shares $218.00 +100.0%N/A0 $1.09
3/31/2021100 shares $105.00 -91.7%N/A0 $1.05
3/15/20211,200 shares $1,152.00 -14.3%N/A0.1 $0.96
2/26/20211,400 shares $1,358.00 -70.8%N/A0 $0.97
2/12/20214,800 shares $4,608.00 -57.1%N/A0.1 $0.96
1/29/202111,200 shares $10,416.00 +1,020.0%N/A0.4 $0.93
1/15/202111,200 shares $9,072.00 +64.7%N/A0.8 $0.81
12/31/20202,500 shares $1,762.50 -77.7%N/A0.1 $0.71
12/15/202011,200 shares $8,904.00 +64.7%N/A0.8 $0.80
11/30/20206,800 shares $5,508.00 +3,300.0%N/A0.1 $0.81
11/15/2020200 shares $120.00 No ChangeN/A0.1 $0.60
9/30/2020200 shares $94.00 +100.0%N/A0 $0.47
9/15/2020100 shares $44.00 No ChangeN/A0 $0.44
8/31/2020100 shares $42.00 No ChangeN/A0 $0.42
8/14/2020100 shares $42.00 No ChangeN/A0.1 $0.42
7/15/20204,500 shares $2,128.50 +4,400.0%N/A1 $0.47
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars (Ad)

Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to help build human colonies on the Red Planet. And here on Earth? Optimus is about to change everything.

There's no time to waste. As far as I can tell, the best way to profit from this project is to make
6/30/2020100 shares $45.00 -50.0%N/A0 $0.45
6/15/2020200 shares $96.00 +100.0%N/A0 $0.48
5/29/2020100 shares $48.50 -96.0%N/A0 $0.49
5/15/20202,500 shares $1,250.00 +47.1%N/A0.2 $0.50
4/30/20201,700 shares $714.00 No ChangeN/A0.1 $0.42

INBP Short Interest - Frequently Asked Questions

What is Integrated BioPharma's current short interest?

Short interest is the volume of Integrated BioPharma shares that have been sold short but have not yet been closed out or covered. As of March 15th, investors have sold 4,800 shares of INBP short. 0.05% of Integrated BioPharma's shares are currently sold short. Learn More on Integrated BioPharma's current short interest.

What is a good short interest percentage for Integrated BioPharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.05% of Integrated BioPharma's floating shares are currently sold short.

Is Integrated BioPharma's short interest increasing or decreasing?

Integrated BioPharma saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 4,800 shares, an increase of 1,500.0% from the previous total of 300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Integrated BioPharma's short interest compare to its competitors?

0.05% of Integrated BioPharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Integrated BioPharma: NRx Pharmaceuticals, Inc. (7.34%), Exicure, Inc. (1.79%), Generation Bio Co. (3.67%), FibroGen, Inc. (5.04%), Tempest Therapeutics, Inc. (4.42%), Estrella Immunopharma, Inc. (0.22%), Cadrenal Therapeutics, Inc. (4.05%), Alterity Therapeutics Limited (0.52%), Akari Therapeutics, Plc (0.71%), Earth Science Tech, Inc. (0.00%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks.

What does it mean to sell short Integrated BioPharma stock?

Short selling INBP is an investing strategy that aims to generate trading profit from Integrated BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Integrated BioPharma?

A short squeeze for Integrated BioPharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INBP, which in turn drives the price of the stock up even further.

How often is Integrated BioPharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INBP, twice per month. The most recent reporting period available is March, 15 2025.




This page (OTCMKTS:INBP) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners